Lonza Launches Next Generation 4D-Nucleofector Cell Transfection Platform with Proven Performance and Enhanced Ease of Use Kumar Jeetendra | May 18, 2021 Basel, Switzerland, 18 May 2021 – Lonza has launched the next generation of its popular Nucleofector® Platform. For more than 20 years, Nucleofector® Technology has led the market as the most effective non-viral cell transfection method, which can be used even for hard-to-transfect cells, such as primary cells and pluripotent stem cells. Now, with an …
Prashant Nagre elevated to the position of Managing Director of Fermenta Biotech Limited Kumar Jeetendra | May 6, 2021 Mr Krishna Datla, Promoter and Managing Director of Fermenta Biotech Limited (FBL) today announced the appointment of Chief Executive Officer, Prashant Nagre, as the new Managing Director with effect from 9th May 2021. Mr Datla will continue as a Board member and the Executive Vice Chairman. The last few years have witnessed implementation of significant …
Takara Bio Europe AB and PanCryos Announce Licensing Agreement to Enable Development of Cell-Based Therapy for Diabetes Kumar Jeetendra | May 5, 2021 Göteberg, Sweden – May 05, 2021 – Life Science Newswire – Takara Bio Europe AB (TBEAB) and PanCryos are pleased to announce that they have reached a licensing agreement surrounding TBEAB’s clinical-grade human embryonic stem (hES) cell lines. PanCryos has established a simplified and effective method to generate stem cell-derived, glucose-responsive beta cells and is …
DefiniGEN appoints Dr Ben Cons as Chairman of its Board Kumar Jeetendra | April 29, 2021 Cambridge, UK – 29 April, 2021 – Life Science Newswire – DefiniGEN, the world leader in human induced pluripotent stem cell (iPSC) differentiation and disease modelling, today announces the appointment of Dr Ben Cons as Chairman of the Board. A respected entrepreneur and pharmaceutical and healthcare leader, he has a proven track record and brings …
Isohelix and AutoGen sign a collaborative supply agreement Kumar Jeetendra | April 28, 2021 Harrietsham, UK & Holliston, USA – (April 28, 2021) – Isohelix, a specialist provider of DNA and RNA sampling and purification products, and AutoGen, Inc., a leading provider of nucleic acid extraction automation, have signed a far-reaching supply agreement. This follows the successful validation of the Isohelix GeneFix™ range of saliva collection products on the …
NDA Group announces Christine Lind as the new VP of Commercial Kumar Jeetendra | April 27, 2021 Sweden – April 27, 2021 –Christine Lind, joins NDA Group as Vice President of Commercial from her most recent role as Strategy and Business Development advisor to BioArctic AB. With over 20 years’ experience in a variety of roles within the Life Science sector, Christine’s track record of both team leadership and successful commercial transactions …
PEAK Scientific launches new Green initiative Kumar Jeetendra | April 22, 2021 PEAK Scientific, the global leader in gas generation for laboratories, today unveiled its latest Green initiative. PEAK Scientific have partnered with eForests, a not-for-profit organization who are creating and restoring woodlands throughout the UK, to fulfil their commitment to plant one tree for every PEAK gas generator sold from the 1st April 2021. The initiative …
Applied Photophysics celebrates 50 years Kumar Jeetendra | April 22, 2021 Leatherhead, UK – 22nd April 2021 – Life Science Newswire – Applied Photophysics (AP) started in Mayfair, London, in April 1971. An unusual place perhaps for a start-up scientific instrument company, was although explained by the fact that the origins of the company lie within the Royal Institution (RI). The Royal Institution has been at …
FBL pioneers the development of its patented enzymatic route of synthesis for Molunpiravir an investigational ‘orally active’ therapeutic alternative for COVID 19 Kumar Jeetendra | April 16, 2021 “With the more we understand of COVID 19 the less we fear it and it is through this understanding that we can potentially create impressive therapeutic developments” says Mr. Prashant Nagre, CEO, FBL as he expounds further on the experimental antiviral drug Molnupiravir. Developed at Emory University in Atlanta by Drug Innovation Ventures at Emory …
Malvern Panalytical and Concept Life Sciences announce integration Kumar Jeetendra | April 14, 2021 Malvern Panalytical (Malvern, UK and Almelo, The Netherlands), manufacturer of analytical systems, and Concept Life Sciences (Cheshire, UK), a contract research organization, have today announced a full business integration. The integration will expand the existing analytical instrument and service relationship (Amplify Analytics) to include the Chemistry and Biology services of CLS. Both entities are operating …
AnteoTech Secures CE Certification for Its Versatile EuGeni™ Rapid Diagnostic Platform Kumar Jeetendra | April 13, 2021 Brisbane, AUS, April 13, 2021 – AnteoTech has announced that its EuGeni™ Reader and accompanying COVID-19 Antigen Rapid Test (ART) have received Conformité Européene (CE) Mark registration as the company looks to progress with European distribution. The digital multi-test EuGeni Reader eliminates the human error associated with current lateral flow test interpretation, and can support …
Hester acquires technology from ICAR – IVRI for the production and commercialization of Classical Swine Fever Vaccine & Sheep Pox Vaccine Kumar Jeetendra | April 8, 2021 8 April 2021: Hester has signed two agreements with ICAR-IVRI (Indian Council of Agricultural Research – Indian Veterinary Research Institute),for acquiring technologies for the production and commercialisation of the following vaccines: 1. Classical Swine Fever Vaccine 2. Sheep Pox Vaccine These vaccines are the first that have been developed within the country by using locally …
